Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Transnational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes That May Support Future Development of Personalized Treatment Strategies in Chinese Population

NCT06419413 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06419413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06419413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Transnational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes That May Support Future Development of Personalized Treatment Strategies in Chinese Population
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
January 8, 2024
Completion date
October 8, 2026
Enrollment
355 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

asthma